thymosin beta-4 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-07-04. Numbers and descriptions here follow the published literature rather than marketing material.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H68N10O14 | Calculated for the acetylated heptapeptide |
| Molecular weight | ~889 Da | Monoisotopic mass approximately 889.0 Da |
| Amino acid sequence | Ac-LKKTETQ | N-terminal acetylated seven-residue peptide |
| Appearance | White to off-white powder | Typically supplied as a lyophilized solid |
| Solubility class | Water-soluble | Peptides of this size generally dissolve in aqueous media |
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
At the end of the electrophoretic separation, all proteins are sorted by size and can then be analyzed by other methods, e. g. protein staining such as Coomassie staining (most common and easy to use), silver staining (highest sensitivity), stains all staining, Amido black 10B staining, Fast green FCF staining, fluorescent stains such as epicocconone stain and SYPRO orange stain, and immunological detection such as the Western Blot. The fluorescent dyes have a comparatively higher linearity between protein quantity and color intensity of about three orders of magnitude above the detection limit (the quantity of protein that can be estimated by color intensity). When using the fluorescent protein dye trichloroethanol, a subsequent protein staining is omitted if it was added to the gel solution and the gel was irradiated with UV light after electrophoresis. In Coomassie staining, gel is fixed in a 50% ethanol 10% glacial acetic acid solution for 1 hr. Then the solution is changed for fresh one and after 1 to 12 hrs gel is changed to a staining solution (50% methanol, 10% glacial acetic acid, 0.1% coomassie brilliant blue) followed by destaining changing several times a destaining solution of 40% methanol, 10% glacial acetic acid.
Each trajectory in a Pfold calculation can be relatively short, but many independent trajectories are needed. Long continuous-trajectory simulations have been performed on Anton, a massively parallel supercomputer designed and built around custom application-specific integrated circuits (ASICs) and interconnects by D. E. Shaw Research. The longest published result of a simulation performed using Anton is a 1.112-millisecond simulation of NTL9 at 355 K; a second, independent 1.073-millisecond simulation of this configuration was also performed (and many other simulations of over 250 μs continuous chemical time). In How Fast-Folding Proteins Fold, researchers Kresten Lindorff-Larsen, Stefano Piana, Ron O. Dror, and David E. Shaw discuss "the results of atomic-level molecular dynamics simulations, over periods ranging between 100 μs and 1 ms, that reveal a set of common principles underlying the folding of 12 structurally diverse proteins." Examination of these diverse long trajectories, enabled by specialized, custom hardware, allow them to conclude that "In most cases, folding follows a single dominant route in which elements of the native structure appear in an order highly correlated with their propensity to form in the unfolded state." In a separate study, Anton was used to conduct a 1.013-millisecond simulation of the native-state dynamics of bovine pancreatic trypsin inhibitor (BPTI) at 300 K. Another important application of MD method benefits from its ability of 3-dimensional characterization and analysis of microstructural evolution at atomic scale.
=== Congressional === In 1995, the Library of Congress established THOMAS, an online archive of the proceedings of the United States Congress, which included the full text of proposed legislation, bill summaries, and statuses, Congressional Record text, and an index of the Congressional Record. In 2005 and again in 2010, the THOMAS system received major updates. A migration to a more modernized Web system, Congress.gov, began in 2012, and the THOMAS system was retired in 2016. Congress.gov is a joint project of the Library of Congress, the House, the Senate, and the Government Publishing Office.
Sources: en.wikipedia.org
== Personal life == Beginning in 2014, Ayyadurai was romantically connected with actress Fran Drescher. On September 7, 2014, Ayyadurai and Drescher participated in a ceremony at Drescher's beach house. Both tweeted that they had gotten married, and the event was widely reported as such. Ayyadurai later said it was not "a formal wedding or marriage", but a celebration of their "friendship in a spiritual ceremony with close friends and her family". The couple split up in September 2016.
Metal and silicate particles, some of which are at higher levels than in traditional cigarettes, have been detected in e-cigarette aerosol, resulting from degradation from the metal coil used to heat the solution. Other materials used are Pyrex glass rather than plastics and stainless steel rather than metal alloys. Metals and metal nanoparticles have been found in tiny amounts in e-cigarette vapor. Aluminum, antimony, barium, boron, cadmium, chromium, copper, iron, lanthanum, lead, magnesium, manganese, mercury, nickel, potassium, silicate, silver, sodium, strontium, tin, titanium, zinc, and zirconium have been found in e-cigarette vapor. Arsenic may leach from the device itself and may end up in the liquid, and then the e-cigarette vapor. Arsenic has been found in some e-liquids, and in e-cigarette vapor. Considerable differences in exposure to metals have been identified from the e-cigarettes tested, particularly metals such as cadmium, lead, and nickel. Poor quality first-generation e-cigarettes produce several metals in their vapor, in some cases the amounts were greater than with cigarette smoke. A 2013 study found metal particles in the e-cigarette vapor were at concentrations 10-50 times less than permitted in inhalation medicines. A 2018 study found significantly higher amounts of metals in e-cigarette vapor samples in comparison with the e-liquids before they came in contact with the customized e-cigarettes that were provided by everyday e-cigarette users. Lead and zinc were 2,000% higher and chromium, nickel, and tin were 600% higher.
Scans conducted during the studies showed that Sharrock's brain exhibited a heightened connection between the conscious and sub-conscious parts of her brain, which may aid easier memory recall – in particular for events that took place earlier in life. In December 2017, a man named Joey DeGrandis was verified as having HSAM by James McGaugh and subsequently featured in an article in Time magazine. DeGrandis also reports having poor short-term memory, indicating that HSAM does not necessarily improve one's short-term memory abilities. A 63-year-old man, anonymised as "The Amazing Memory Man" (MM) was featured in a paper by Neuropsychology in March 2018, where it is reported that he "appreciates that his memory for personally experienced life events and general knowledge are both exceptional, whereas his imaging the future is only average" (after scoring 123 on Episodic, 123 on Semantic, 112 on Spatial, and 91 on Future remembering memory types, all with a mean of 100). In October 2018, it was reported that teenager Tyler Hickenbottom, who is an identical twin, had the condition, which allowed him to "remember every day of his life like it was yesterday". Tim Rogers, an American video game developer and journalist, claims to experience the condition in several of his published works. John Romero, a video game developer and co-founder of id Software, has often said he has hyperthymesia, including in his 2023 autobiography, Doom Guy: Life in First Person. In 2024, Emily Nash, an 18-year-old high school student with HSAM, was featured in a CTV W5 story.
1993/2131) Courts and Legal Services Act 1990 (Commencement No. 9) Order 1993 (S.I. 1993/2132) Rules of the Supreme Court (Amendment) 1993 (S.I. 1993/2133) Leasehold Reform, Housing and Urban Development Act 1993 (Commencement and Transitional Provisions No. 1) Order 1993 (S.I. 1993/2134) Edinburgh Assay Office (Amendment) Order 1993 (S.I. 1993/2135) County Court (Amendment No. 2) Rules 1993 (S.I. 1993/2150) Combined Probation Areas (Hertfordshire) Order 1993 (S.I. 1993/2151) Manchester, Liverpool Road (Castlefield Properties Limited) Light Railway Order 1993 (S.I. 1993/2153) East Kent Light Railway Order 1993 (S.I. 1993/2154) Mental Health (Nurses) Amendment Order 1993 (S.I. 1993/2155) Mental Health (Hospital, Guardianship and Consent to Treatment) Amendment Regulations 1993 (S.I. 1993/2156) Leasehold Reform, Housing and Urban Development Act 1993 (Commencement No. 2) (Scotland) Order 1993 (S.I. 1993/2163) Housing (Preservation of Right to Buy) (Scotland) Regulations 1993 (S.I. 1993/2164) Employment Protection (Continuity of Employment) Regulations 1993 (S.I. 1993/2165) Controlled Drugs (Substances Useful for Manufacture) (Intra–Community Trade) Regulations 1993 (S.I. 1993/2166) Tobacco Products (Amendment) Regulations 1993 (S.I. 1993/2167) A45/A452 Trunk Roads (Stonebridge Grade Separation) Order 1993 (S.I. 1993/2168) Education (Further Education Institutions Information) (Wales) Regulations 1993 (S.I. 1993/2169) A45 Trunk Road (Middle Bickenhill to Stonebridge) (De-Trunking) Order 1993 (S.I.
Sources: en.wikipedia.org
Two types of strands are created simultaneously during replication: the leading strand, which is synthesized continuously and grows towards the replication fork, and the lagging strand, which is made discontinuously in Okazaki fragments and grows away from the replication fork. Okazaki fragments are covalently joined by DNA ligase to form a continuous strand. Then, to complete DNA replication, RNA primers are removed, and the resulting gaps are replaced with DNA and joined via DNA ligase.
== Food storage and preservation == Food storage and preservation is a key component of food engineering processes and relies heavily on biological engineering to understand and manipulate the organisms involved. Note that the above food safety processes such as pasteurization and sterilization destroy the microorganisms that also contribute to deterioration of food products while not necessarily posing a risk to people. Understanding of these processes, their effects, and the microorganisms at play in various food processing techniques is a very important biological engineering task within food engineering. Factories and processes must be created to ensure that food products can be processed in an efficient and effective manner, which again relies heavily on biological engineering expertise.
The history of fungaria is closely tied to the early development of botanical herbaria, the oldest of which date to the mid-1500s. Fungal fruiting bodies have been collected and deposited for several centuries, with millions of specimens accumulated chiefly to support fungal taxonomy. Early collections were often personal assemblages or teaching aids used to distinguish edible mushrooms from poisonous ones. Over time, fungal herbaria shifted from keeping one or a few representative specimens per taxon toward documenting developmental stages and geographic variation within species more broadly. In some regions, fungaria developed in close association with government plant-pathology programmes; in South Africa, for example, organised collecting expanded after the creation of a mycology post in 1905 and a separate Division of Plant Pathology and Mycology in 1910, whose early staff built the nucleus of the Pretoria herbarium. At the Royal Botanic Gardens, Kew, the mycological collection was established in the late 19th century after the donation of more than 10,000 fungal specimens by the mycologist Reverend Miles Joseph Berkeley. It was later enlarged through donations and collecting by staff and collaborators. More generally, fungaria were often built through a combination of personal collections, academic donations, and purchased exsiccatae series, drawing on wider networks of scientific exchange among mycologists.
=== Criminal justice and cannabis legalization === In 2014, Newsom was the only statewide politician to endorse California Proposition 47, legislation that recategorized certain nonviolent offenses from felonies to misdemeanors, including shoplifting, grand theft, and receiving stolen property valued at under $950. Voters passed the measure on November 4, 2014. In July 2015, Newsom released the Blue Ribbon Commission on Marijuana Policy's final report, which he had convened with the American Civil Liberties Union of California in 2013. The report's recommendations to regulate cannabis were intended to inform a legalization measure on the November 2016 ballot. Newsom supported the resulting measure, Proposition 64, which legalized cannabis use and cultivation for California state residents who are 21 or older. On February 24, 2017, in response to pro-enforcement statements by White House Press Secretary Sean Spicer, Newsom sent Attorney General Jeff Sessions and President Donald Trump a letter urging them not to increase federal enforcement against recreational cannabis firms opening in California. He wrote: "The government must not strip the legal and publicly supported industry of its business and hand it back to drug cartels and criminals ... Dealers don't card kids.
Beta hairpin Extremely common. Two antiparallel beta strands connected by a tight turn of a few amino acids between them. Greek key Four beta strands, three connected by hairpins, the fourth folded over the top. Omega loop A loop in which the residues that make up the beginning and end of the loop are very close together. Helix-loop-helix Consists of alpha helices bound by a looping stretch of amino acids. This motif is seen in transcription factors. Zinc finger Two beta strands with an alpha helix end folded over to bind a zinc ion. Important in DNA binding proteins. Helix-turn-helix Two α helices joined by a short strand of amino acids and found in many proteins that regulate gene expression. Nest Extremely common. Three consecutive amino acid residues form an anion-binding concavity. Niche Extremely common. Three or four consecutive amino acid residues form a cation-binding feature.
Sources: en.wikipedia.org
TB-500 is a synthetic heptapeptide corresponding to a fragment of thymosin beta-4. It is used in laboratory research and is not an approved drug.
No. Thymosin beta-4 is a 43-amino-acid protein, while TB-500 represents only a short N-terminal segment. The two should not be treated as interchangeable in experimental design.
It is often called a thymosin beta-4 fragment, Tβ4 fragment, or Ac-LKKTETQ. The name TB-500 is mainly a commercial or catalog label rather than a formal chemical name.
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.